RESTON,
Va., July 9, 2024 /PRNewswire/ --
Leidos (NYSE: LDOS), a Fortune® 500 innovation company, has
been awarded the Medicaid Enterprise Systems Integrator contract by
North Dakota Health and Human Services. Leidos will provide systems
integration support to transition North
Dakota's existing Medicaid Management Information Systems to
an integrated, scalable, and secure modular system.
"Transitioning North Dakota's legacy Medicaid systems to a
modern system will help provide a better healthcare experience for
patients, providers and administrators," said Liz Porter, Leidos Health & Civil Sector
President. "Building on our strength of innovation and proven
expertise in technology modernization, we look forward to
delivering tailored solutions that empower data-driven decision
making. This modernization project will help position North Dakota to embrace and harness future
advancements."
Leidos will support North
Dakota's goals of improving health outcomes and ensuring
efficient, effective, and economical management of its Medicaid
program through Medicaid Enterprise Systems (MES) modernization.
MES involves a comprehensive set of technologies and solutions that
manage and administer benefits in compliance with federal and state
regulations. Leidos will collaborate with North Dakota Health and
Human Services to meet the unique challenges of modernizing MES,
optimizing data management, ensuring interoperability, and
executing seamless transition.
To learn more, read about Leidos' Medicaid systems solutions or
visit www.leidos.com/civilian-health.
About Leidos
Leidos is a Fortune 500® innovation company rapidly addressing
the world's most vexing challenges in national security and health.
The company's global workforce of 47,000 collaborates to create
smarter technology solutions for customers in heavily regulated
industries. Headquartered in Reston,
Virginia, Leidos reported annual revenues of approximately
$15.4 billion for the fiscal year
ended December 29, 2023. For more
information, visit www.leidos.com.
Certain statements in this announcement constitute
"forward-looking statements" within the meaning of the rules and
regulations of the U.S. Securities and Exchange Commission
(SEC). These statements are based on management's current
beliefs and expectations and are subject to significant risks and
uncertainties. These statements are not guarantees of future
results or occurrences. A number of factors could cause our actual
results, performance, achievements, or industry results to be
different from the results, performance, or achievements expressed
or implied by such forward-looking statements. These factors
include, but are not limited to, the "Risk Factors" set forth in
Leidos' Annual Report on Form 10-K for the fiscal year ended
December 29, 2023, and other such
filings that Leidos makes with the SEC from time to time. Readers
are cautioned not to place undue reliance on such forward-looking
statements, which speak only as of the date hereof. Leidos
does not undertake to update forward-looking statements to reflect
the impact of circumstances or events that arise after the date the
forward-looking statements were made.
Contact:
Melissa Dueñas
(571) 526-6850
duenasml@leidos.com
Alyssa Pettus
(571) 526-6743
alyssa.t.pettus@leidos.com
Brandon Ver Velde
(571) 526-6257
brandon.p.vervelde@leidos.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/leidos-awarded-medicaid-enterprise-systems-integrator-contract-302191078.html
SOURCE Leidos Holdings, Inc.